Virology Research in Taiwan

Dear Colleagues,

Taiwan has experienced several viral epidemics and outbreaks over the past few decades, including enteric viruses (enterovirus, coxsackievirus, norovirus, etc.), dengue virus, hepatitis viruses, influenza viruses, and rabies virus, and has faced both the Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease 2019 (COVID-19) pandemics. These viral diseases are of clinical importance to the Taiwanese population, and research efforts in the nation in the past have significantly contributed to the understanding of the underlying viral pathogenesis and also helped antiviral and vaccine development. Taiwan’s agriculture is also at risk of important animal and plant viruses that affect livestock, crops, and aquaculture and has observed continuous research efforts in these areas as well. At the same time, emerging research in Taiwan has seen the development of viruses for treatment of diseases (e.g., oncolytic viruses and phage therapy) and as delivery vehicles (e.g., for therapeutic gene expression).

This Special Issue covers all aspects of virology research in Taiwan, including molecular virology, viral genomics, viral pathogenesis, virus-host interaction, viral immunology, clinical virology, epidemiology, antiviral development, vaccine development, diagnostics, in vitro/in vivo viral model development, viral vector application, and viral oncolytics, among others. We invite researchers in Taiwan to submit to this Special Issue.

Prof. Dr. Liang-Tzung Lin
Prof. Dr. Ya-Chung Tian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.